Pregnancy characteristics and women's future cardiovascular health: An underused opportunity to improve women's health?

Epidemiologic Reviews

Volumn 36, Issue 1, 2014, Pages 57-70

  Rich Edwards, Janet W ^a   Fraser, Abigail ^a   Lawlor, Deborah A ^a   Catov, Janet M ^a  

^a OBC 334 ^*  (United States)

Author keywords

birth weight; cardiovascular disease; diabetes, gestational; preeclampsia; pregnancy; premature birth; women's health

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE;

ARTICLE; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; ENVIRONMENTAL FACTOR; FEMALE; GESTATIONAL AGE; HEALTH CARE POLICY; HEART DISEASE; HEART INFARCTION; HIGH RISK PREGNANCY; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; INTRAUTERINE GROWTH RETARDATION; ISCHEMIC HEART DISEASE; LIFESTYLE; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL RESEARCH; MEDLINE; PARITY; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SCREENING; SMALL FOR DATE INFANT; SMOKING; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM; WOMEN'S HEALTH;

BIRTH WEIGHT; CARDIOVASCULAR DISEASE; DIABETES, GESTATIONAL; PREECLAMPSIA; PREGNANCY; PREMATURE BIRTH; WOMEN'S HEALTH;

BIRTH WEIGHT; CARDIOVASCULAR DISEASES; CAUSALITY; COMORBIDITY; DIABETES, GESTATIONAL; FEMALE; FETAL DEVELOPMENT; FETAL MACROSOMIA; HUMANS; HYPERTENSION; INCIDENCE; MATERNAL MORTALITY; PARITY; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREMATURE BIRTH; RISK ASSESSMENT; WOMEN'S HEALTH;

EID: 84891542483     PISSN: 0193936X     EISSN: 14786729     Source Type: Journal    
DOI: 10.1093/epirev/mxt006     Document Type: Article

References (161)

1. Rich-Edwards JW. Reproductive health as a sentinel of chronic disease in women. Womens Health (Lond Engl). 2009;5(2):101-105.
2. Decline in deaths from heart disease and stroke-United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999; 48(30):649-656.
3. Yusuf S, Reddy S, Ôunpuu S, et al. Global burden of cardiovascular diseases. Circulation. 2001;104(22): 2746-2753.
4. Shah RU, Klein L, Lloyd-Jones DM. Heart failure in women: epidemiology, biology and treatment. Womens Health (Lond Engl). 2009;5(5):517-527.
5. Mathers C, Boerma JT, Fat DM, et al the Global Burden of Disease: 2004 Update. Geneva, Switzerland:World Health Organization; 2008.
6. Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-sponsoredWomen's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and genderoptimized diagnostic strategies. J Am Coll Cardiol. 2006; 47(suppl 3):S4-S20.
7. Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation. 2011;123(11):1243-1262.
8. Shay CM, Ning H, Allen NB, et al. Status of cardiovascular health in US adults: clinical perspective prevalence estimates from the National Health and Nutrition Examination Surveys (NHANES) 2003-2008. Circulation. 2012;125(1):45-56.
9. Chronic disease reports in the Morbidity and Mortality Weekly Report (MMWR). MMWR Morb Mortal Wkly Rep. 1989;38(suppl 1):1-8.
10. Scarborough P,Weissberg P. Trends in Coronary Heart Disease, 1961-2011. London, United Kingdom: British Heart Foundation; 2011.
11. Labarthe DR. Prevention of cardiovascular risk factors in the first place. Prev Med. 1999;29(6 Pt 2):S72-S78.
12. Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2011;124(8):967-990.
13. Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325(7356):157-160.
14. Martinez G, Daniels K, Chandra A. Fertility of men and women aged 15-44 years in the United States: National Survey of Family Growth, 2006-2010. Natl Health Stat Report. 2012;51:1-28.
15. SF2.5 report on childlessness. Paris, France: Social Policy Division, Organisation for Economic Co-operation and Development; 2010. (www.oecd.org/social/family/database). (Accessed June 24, 2013).
16. World Fertility Report 2009. New York, NY: Department of Economic and Social Affairs, Population Division, United Nations; 2011.
17. Fraser A, Nelson SM, Macdonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age. Circulation. 2012;125(11):1367-1380.
18. Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007; 335(7627):974.
19. Kestenbaum B, Seliger SL, Easterling TR, et al. Cardiovascular and thromboembolic events following hypertensive pregnancy. Am Jf Kidney Dis. 2003;42(5): 982-989.
20. Irgens HU, Reisaeter L, Irgens LM, et al. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ. 2001;323(7323): 1213-1217.
21. Wikström AK, Haglund B, Olovsson M, et al the risk of maternal ischaemic heart disease after gestational hypertensive disease. BJOG. 2005;112(11):1486-1491.
22. Green A, Beral V, Moser K. Mortality in women in relation to their childbearing history. BMJ. 1988;297(6645):391-395.
23. Ness RB, Harris T, Cobb J, et al. Number of pregnancies and the subsequent risk of cardiovascular disease. N Engl J Med. 1993;328(21):1528-1533.
24. Steenland K, Lally C, Thun M. Parity and coronary heart disease among women in the American Cancer Society CPS II population. Epidemiology. 1996;7(6):641-643.
25. Parikh NI, Cnattingius S, Dickman PW, et al. Parity and risk of later-life maternal cardiovascular disease. Am Heart J. 2010;159(2):215-221.
26. Ness RB, Cobb J, Harm T, et al. Does number of children increase the rate of coronary heart disease in men? Epidemiology. 1995;6(4):442-445.
27. Lawlor DA, Emberson JR, Ebrahim S, et al. Is the association between parity and coronary heart disease due to biological effects of pregnancy or adverse lifestyle risk factors associated with child-rearing? Circulation. 2003;107(9):1260-1264.
28. Dekker JM, Schouten EG. Number of pregnancies and risk of cardiovascular disease. N Engl J Med. 1993;329(25): 1893-1894; author reply 1894-1895.
29. Davey-Smith G, Harding S, Rosato M. Relation between infants' birth weight and mothers' mortality: prospective observational study. BMJ. 2000;320(7238):839-840.
30. Davey-Smith G, Hart C, Ferrell C, et al. Birth weight of offspring and mortality in the Renfrew and Paisley study: prospective observational study. BMJ. 1997;315(7117): 1189-1193.
31. Davey-Smith G, Hypponen E, Power C, et al. Offspring birth weight and parental mortality: prospective observational study and meta-analysis. Am J Epidemiol. 2007;166(2): 160-169.
32. Davey-Smith G, Whitley E, Gissler M, et al. Birth dimensions of offspring, premature birth, and the mortality of mothers. Lancet. 2000;356(9247):2066-2067.
33. Catov J, Newman A, Roberts J, et al. Association between infant birth weight and maternal cardiovascular risk factors in the Health, Aging, and Body Composition Study. Ann Epidemiol. 2007;17(1):36-43.
34. Smith GC, Pell JP,Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet. 2001;357(9273): 2002-2006.
35. Friedlander Y, Paltiel O, Manor O, et al. Birthweight of offspring and mortality of parents: the Jerusalem perinatal study cohort. Ann Epidemiol. 2007;17(11):914-922.
36. Bonamy AK, Parikh NI, Cnattingius S, et al. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth. Circulation. 2011;124(25):2839-2846.
37. Lykke JA, Langhoff-Roos J, Lockwood CJ, et al. Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr Perinat Epidemiol. 2010;24(4):323-330.
38. Davey-Smith G, Sterne J, Tynelius P, et al. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology. 2005;16(4):563-569.
39. Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the Child Health and Development Studies cohort. Hypertension. 2010;56(1):166-171.
40. Lykke JA, Paidas MJ, Triche EW, et al. Fetal growth and later maternal death, cardiovascular disease and diabetes. Acta Obstet Gynecol Scand. 2012;91(4):503-510.
41. Metzger BE, Cho NH, Roston SM, et al. Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care. 1993;16(12):1598-1605.
42. Lie RT,Wilcox AJ, Skjaerven R. Maternal and paternal influences on length of pregnancy. Obstet Gynecol. 2006; 107(4):880-885.
43. Freathy RM,Weedon MN, Bennett A, et al. Type 2 diabetes TCF7L2 risk genotypes alter birth weight: a study of 24,053 individuals. Am J Hum Genet. 2007;80(6):1150-1161.
44. Beck S,Wojdyla D, Say L, et al the worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity. Bull World Health Organ. 2010;88(1):31-38.
45. Lykke J, Paidas M, Damm P, et al. Preterm delivery and risk of subsequent cardiovascular morbidity and type?II diabetes in the mother. BJOG. 2010;117(3):274-281.
46. Catov JM, Wu CS, Olsen J, et al. Early or recurrent preterm birth and maternal cardiovascular disease risk. Ann Epidemiol. 2010;20(8):604-609.
47. Nardi O, Zureik M, Courbon D, et al. Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control study. Eur J Cardiovasc Prev Rehabil. 2006;13(2):281-283.
48. Pell JP, Smith GC,Walsh D. Pregnancy complications and subsequent maternal cerebrovascular events: a retrospective cohort study of 119,668 births. Am J Epidemiol. 2004; 159(4):336-342.
49. Rich-Edwards JW, Klongsoyr K, Wilcox A, et al. Duration of first pregnancy predicts maternal cardiovascular death, whether delivery was medically indicated or spontaneous [abstract]. Am J Epidemiol. 2012;175(suppl 11):S64.
50. Hastie CE, Smith GC, MacKay DF, et al. Maternal risk of ischaemic heart disease following elective and spontaneous pre-term delivery: retrospective cohort study of 750 350 singleton pregnancies. Int J Epidemiol. 2011;40(4):914-919.
51. Wilcox AJ, Skjaerven R, Lie RT. Familial patterns of preterm delivery: maternal and fetal contributions. Am J Epidemiol. 2008;167(4):474-479.
52. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773-1779.
53. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862-1868.
54. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215-2222.
55. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care. 2008;31(8):1668-1669.
56. Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care. 2006;29(9):2078-2083.
57. Retnakaran R, Shah BR. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med. 2009;26(5):474-477.
58. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: a populationbased cohort study. CMAJ. 2009;181(6-7):371-376.
59. Wallis AB, Saftlas AF, Hsia J, et al. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004. Am J Hypertens. 2008;21(5): 521-526.
60. Roberts CL, Algert CS, Morris JM, et al. Hypertensive disorders in pregnancy: a population-based study. Med J Aust. 2005;182(7):332-335.
61. McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918-930.
62. Lin Y-S, Tang C-H, Yang C-YC, et al. Effect of preeclampsia-eclampsia on major cardiovascular events among peripartum women in Taiwan. Am J Cardiol. 2011; 107(2):325-330.
63. Lykke JA, Langhoff-Roos J, Sibai BM, et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009;53(6):944-951.
64. Wilson BJ,Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003; 326(7394):845.
65. Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology. 2005;16(2): 206-215.
66. Hannaford P, Ferry S, Hirsch S. Cardiovascular sequelae of toxaemia of pregnancy. Heart. 1997;77(2):154-158.
67. Jónsdóttir L, Arngrimsson R, Geirsson RT, et al. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 1995;74(10):772-776.
68. Skjaerven R,Wilcox AJ, Klungsoyr K, et al. Cardiovascular mortality after pre-eclampsia in one child mothers: prospective, population based cohort study. BMJ. 2012; 345:e7677.
69. Retnakaran R, Austin PC, Shah BR. Effect of subsequent pregnancies on the risk of developing diabetes following a first pregnancy complicated by gestational diabetes: a population-based study. Diabet Med. 2011;28(3):287-292.
70. Magnussen EB, Vatten LJ, Lund-Nilsen TI, et al. Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study. BMJ. 2007;335:978.
71. Catov JM, Nohr EA, Olsen J, et al. Chronic hypertension related to risk for preterm and term small-for-gestational-age births. Obstet Gynecol. 2008;112(2 Pt 1):290-296.
72. Magnussen EB, Vatten LJ, Myklestad K, et al. Cardiovascular risk factors prior to conception and the length of pregnancy: population-based cohort study. Am J Obstet Gynecol. 2011;204(6):526.e521-526.e528.
73. Catov JM, Ness RB,Wellons MF, et al. Prepregnancy lipids related to preterm birth risk: the Coronary Artery Risk Development in Young Adults Study. J Clin Endocrinol Metab. 2010;95(8):2009-2028.
74. Romundstad PR, Davey Smith G, Nilsen TI, et al. Associations of prepregnancy cardiovascular risk factors with the offspring's birth weight. Am J Epidemiol. 2007;166(12):1359-1364.
75. Solomon CG,Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA. 1997;278(13):1078-1083.
76. Riskin-Mashiah S, Damti A, Younes G, et al. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol. 2010;152(2):163-167.
77. Sacks DA, ChenW,Wolde-Tsadik G, et al. Fasting plasma glucose test at the first prenatal visit as a screen for gestational diabetes. Obstet Gynecol. 2003;101(6):1197-1203.
78. Nanda S, Savvidou M, Syngelaki A, et al. Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks. Prenat Diagn. 2011; 31(2):135-141.
79. Williams MA, Qiu C, Muy-Rivera M, et al. Plasma adiponectin concentrations in early pregnancy and subsequent risk of gestational diabetes mellitus. J Clin Endocrinol Metab. 2004;89(5):2306-2311.
80. Lain KY, Daftary AR, Ness RB, et al. First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf). 2008;69(3):407-411.
81. Qiu C,Williams MA, Leisenring WM, et al. Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension. 2003;41(3):408-413.
82. O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology. 2003;14(3):368-374.
83. Romero R, Espinoza J, Gonçalves LF, et al the role of inflammation and infection in preterm birth [abstract]. Semin Reprod Med. 2007;25(1):21-39.
84. Monga M, Creasy R. Cardiovascular and renal adaptation to pregnancy. In: Creasy R, Resnik R, Iams JD, et al, eds. Maternal-Fetal Medicine: Principles and Practice. Philadelphia, PA:WB Saunders; 1994:758-767.
85. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71(5 suppl):1256S-1261S.
86. Potter J, Nestel P the hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol. 1979;133(2):165-170.
87. Hubel C, Shakir Y, Gallaher M, et al. Low-density lipoprotein particle size decreases during normal pregnancy in association with triglyceride increases. J Soc Gynecol Investig. 1998;5(5):244-250.
88. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr. 2000;54(suppl 1):S47-S51.
89. Ducey J, Schulman H, Farmakides G, et al. A classification of hypertension in pregnancy based on Doppler velocimetry. Am J Obstet Gynecol. 1987;157(3):680-685.
90. Campbell S, Griffin DR, Pearce JM, et al. New Doppler technique for assessing uteroplacental blood flow. Lancet. 1983;321(8326):675-677.
91. Savvidou MD, Hingorani AD, Tsikas D, et al. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet. 2003;361(9368):1511-1517.
92. Savvidou MD, Kaihura C, Anderson JM, et al. Maternal arterial stiffness in women who subsequently develop preeclampsia. PLoS ONE. 2011;6(5):e18703.
93. Kelly R, Holzman C, Senagore P, et al. Placental vascular pathology findings and pathways to preterm delivery. Am J Epidemiol. 2009;170(2):148-158.
94. Clausen T, Djurovic S, Henriksen T. Dyslipidemia in early second trimester is mainly a feature of women with early onset pre-eclampsia. BJOG. 2001;108(10):1081-1087.
95. Hubel CA, McLaughlin MK, Evans RW, et al. Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol. 1996;174(3):975-982.
96. Hubel CA, Lyall F,Weissfeld L, et al. Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia. Metabolism. 1998;47(10):1281-1288.
97. Sattar N, Bendomir A, Berry C, et al. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89(3): 403-408.
98. Edison RJ, Berg K, Remaley A, et al. Adverse birth outcomes among mothers with low serum cholesterol. Pediatrics. 2007;120(4):723-733.
99. Catov JM, Bodnar LM, Kip KE, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007;197(6):610.e611-610. e617.
100. Enquobahrie DA, Williams MA, Qiu C, et al. Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res Clin Pract. 2005;70(2): 134-142.
101. Sattar N, Greer I, Galloway P, et al. Lipid and lipoprotein concentrations in pregnancies complicated by intrauterine growth restriction. J Clin Endocrinol Metab. 1999; 84(1):128-130.
102. Wadsack C, Tabano S, Maier A, et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition. Am J Physiol Endocrinol Metab. 2007;292(2):476-484.
103. Stepan H, Faber R,Walther T. Expression of low density lipoprotein receptor messenger ribonucleic acid in placentas from pregnancies with intrauterine growth retardation. Br J Obstet Gynaecol. 1999;106(11):1221-1222.
104. Ostlund I, Haglund B, Hanson U. Gestational diabetes and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2004; 113(1):12-16.
105. Hedderson MM, Ferrara A, Sacks DA. Gestational diabetes mellitus and lesser degrees of pregnancy hyperglycemia: association with increased risk of spontaneous preterm birth. Obstet Gynecol. 2003;102(4):850-856.
106. Lawlor DA, Relton C, Sattar N, et al. Maternal adiposity-a determinant of perinatal and offspring outcomes? Nat Rev Endocrinol. 2012;8(11):679-688.
107. Smith GCS, Shah I, Pell JP, et al. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health. 2007;97(1):157-162.
108. Ernst GDS, de Jonge LL, Hofman A, et al. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study. Am J Obstet Gynecol. 2011;205(2): 132.e1-132.e12.
109. PitiphatW, Gillman MW, Joshipura KJ, et al. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol. 2005;162(11):1108-1113.
110. Catov JM, Bodnar LM, Ness RB, et al. Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol. 2007;166(11):1312-1319.
111. Wolf M, Kettyle E, Sandler L, et al. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol. 2001;98(5):757-762.
112. Freeman DJ, McManus F, Brown EA, et al. Short-and longterm changes in plasma inflammatory markers associated with preeclampsia. Hypertension. 2004;44(5):708-714.
113. Curry A, Vogel I, Drews C, et al. Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery. Acta Obstet Gynecol Scand. 2007;86(9):1103-1110.
114. Gammill HS, Powers RW, Clifton RG, et al. Does C-reactive protein predict recurrent preeclampsia? Hypertens Pregnancy. 2010;29(4):399-409.
115. Heilmann L, RathW, Pollow K. Hemostatic abnormalities in patients with severe preeclampsia. Clin Appl Thromb Hemost. 2007;13(3):285-291.
116. Catov J, Bodnar L, Hackney D, et al. Activation of the fibrinolytic cascade early in pregnancy among women with spontaneous preterm birth. Obstet Gynecol. 2008;112(5): 1116-1122.
117. Hackney DN, Catov JM, Simhan HN. Low concentrations of thrombin-inhibitor complexes and the risk of preterm delivery. Am J Obstet Gynecol. 2010;206(2):184.e181-184. e186.
118. Girardi G. Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation. Thromb Res. 2011;127(suppl 3):S43-S46.
119. Gunderson EP, Lewis CE, Murtaugh MA, et al. Long-term plasma lipid changes associated with a first birth: the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol. 2004;159(11):1028-1039.
120. Gore SA, Brown DM,West DS the role of postpartum weight retention in obesity among women: a review of the evidence. Ann Behav Med. 2003;26(2):149-159.
121. Gunderson E, Murtaugh M, Lewis C, et al. Excess gains in weight and waist circumference associated with childbearing: the Coronary Artery Risk Development in Young Adults Study (CARDIA). Int J Obes. 2004;28(4):525-535.
122. Schwarz EB, Ray RM, Stuebe AM, et al. Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol. 2009;113(5):974-982.
123. Gunderson EP, Sternfeld B,Wellons MF, et al. Childbearing may increase visceral adipose tissue independent of overall increase in body fat. Obesity. 2008;16(5):1078-1084.
124. Stuebe AM, Rich-Edwards JW the reset hypothesis: lactation and maternal metabolism. Am J Perinatol. 2009; 26(1):81-88.
125. Lykke JA, Paidas MJ, Langhoff-Roos J. Recurring complications in second pregnancy. Obstet Gynecol. 2009;113(6):1217-1224.
126. Ananth CV, Getahun D, Peltier MR, et al. Recurrence of spontaneous versus medically indicated preterm birth. Am J Obstet Gynecol. 2006;195(3):643-650.
127. Bloom SL, Yost NP, McIntire DD, et al. Recurrence of preterm birth in singleton and twin pregnancies. Obstet Gynecol. 2001;98(3):379-385.
128. Agatisa PK, Ness RB, Roberts JM, et al. Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. Am J Physiol Heart Circ Physiol. 2004;286(4):H1389-H1393.
129. Lawlor D, Davey Smith G, Ebrahim S. Birth weight of offspring and insulin resistance in late adulthood: cross sectional survey. BMJ. 2002;325(7360):359- 362.
130. Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension. 2008;51(4):1034-1041.
131. Catov JM, Dodge R, Yamal JM, et al. Prior preterm or smallfor- gestational-age birth related to maternal metabolic syndrome. Obstet Gynecol. 2011;117(2 Pt 1):225-232.
132. Macdonald-Wallis C, Lawlor DA, Fraser A, et al. Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension. 2012;59(6):1241-1248.
133. Lauenborg J, Mathiesen E, Hansen T, et al the prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab. 2005;90(7):4004-4010.
134. Meyers-Seifer CH, Vohr BR. Lipid levels in former gestational diabetic mothers. Diabetes Care. 1996; 19(12):1351-1356.
135. Verma A, Boney CM, Tucker R, et al. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab. 2002;87(7):3227-3235.
136. Heitritter SM, Solomon CG, Mitchell GF, et al. Subclinical inflammation and vascular dysfunction in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 2005;90(7):3983-3988.
137. Anastasiou E, Lekakis JP, Alevizaki M, et al. Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care. 1998; 21(12):2111-2115.
138. Tarim E, Yigit F, Kilicdag E, et al. Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol. 2006;27(2):177-182.
139. Manten GT, Sikkema MJ, Voorbij HA, et al. Risk factors for cardiovascular disease in women with a history of pregnancy complicated by preeclampsia or intrauterine growth restriction. Hypertens Pregnancy. 2007;26(1): 39-50.
140. Magnussen EB, Vatten LJ, Smith GD, et al. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol. 2009;114(5): 961-970.
141. Sattar N, Ramsay J, Crawford L, et al. Classic and novel risk factor parameters in women with a history of preeclampsia. Hypertension. 2003;42(1):39-42.
142. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab. 1996;81(8):2908-2911.
143. Hubel CA, Powers RW, Snaedal S, et al. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension. 2008;51(6):1499-1505.
144. Romundstad PR, Magnussen EB, Smith GD, et al. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010;122(6):579-584.
145. Smith GN, Walker MC, Liu A, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol. 2009; 200(1):e51-e58.
146. Di Cianni G, Lencioni C, Volpe L, et al. C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes Metab Res Rev. 2007;23(2):135-140.
147. Kanagalingam MG, Nelson SM, Freeman DJ, et al. Vascular dysfunction and alteration of novel and classic cardiovascular risk factors in mothers of growth restricted offspring. Atherosclerosis. 2009;205(1):244-250.
148. Wolf M, Hubel CA, Lam C, et al. Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance. J Clin Endocrinol Metab. 2004; 89(12):6239-6243.
149. James-Todd TM, Karumanchi SA, Hibert EL, et al. Gestational age, birth weight and subsequent risk of type 2 diabetes in mothers. Preventing Chronic Dis. In press.
150. Hastie CE, Smith GCS, Mackay DF, et al. Association between preterm delivery and subsequent C-reactive protein: a retrospective cohort study. Am J Obstet Gynecol. 2011; 205(6):556.e551-556.e554.
151. Hubel CA, Powers R, Snaedal S, et al. C-reactive protein is increased 30 years after eclamptic pregnancy. J Soc Gynecol Invest. 2006;13(suppl 2):292A.
152. Winzer C,Wagner O, Festa A, et al. Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care. 2004;27(7):1721-1727.
153. Portelinha A, Cerdeira AS, Belo L, et al. Haemostatic factors in women with history of preeclampsia. Thromb Res. 2009;124(1):52-56.
154. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2010;122(25): e584-e636.
155. Shaat N, Lernmark A, Karlsson E, et al. Avariant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus. Diabetologia. 2007;50(5):972-979.
156. Lauenborg J, Grarup N, Damm P, et al. Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab. 2009;94(1):145-150.
157. Cho YM, Kim TH, Lim S, et al. Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia. 2009;52(2): 253-261.
158. Kwak SH, Kim SH, Cho YM, et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes. 2012;61(2):531-541.
159. Bytautiene E, Lu F, Tamayo EH, et al. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol. 2010;298(1): H189-H193.
160. Regitz-Zagrosek V, Lundqvist CB, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24): 3147-3197.
161. Rich-Edwards JW, McElrath TF, Karumanchi SA, et al. Breathing life into the lifecourse approach: pregnancy history and cardiovascular disease in women. Hypertension. 2010; 56(3):331-334.